Production of poly-3-hydroxybutyrate (PHB) nanoparticles using grape residues as the sole carbon source

Autor: Andler, R., González-Arancibia, F., Vilos, C., Sepulveda-Verdugo, R., Castro, R., Mamani, M., Valdés, C., Arto-Paz, F., Díaz-Barrera, A., Martínez, I.

Publikováno v: In International Journal of Biological Macromolecules March 2024 261 Part 2

Evaluation of ceftiofur–PHBV microparticles in rats

Autor: Vilos C, Constandil L, Rodas PI, Cantin M, Zepeda K, Herrera N, Velasquez LA

Publikováno v: Drug Design, Development and Therapy, Vol 2014, Iss default, Pp 651-666 (2014)

Cristian Vilos,1,3 Luis Constandil,2,3 Paula I Rodas,1,3 Mario Cantin,4,5 Katherine Zepeda,1 Natalia Herrera,1 Luis A Velasquez1,3 1Center for Integrative Medicine and Innovative Science (CIMIS), Faculty of Medicine, Universidad Andres Bello, Santiag

Externí odkaz: https://doaj.org/article/46d4fc54e4464c69ac5af945de64216a

The Human Dermis as a Target of Nanoparticles for Treating Skin Conditions.

Autor: Salazar J; Laboratory of Nanomedicine and Targeted Delivery, School of Medicine, Universidad de Talca, Talca 3460000, Chile.; Departamento de Química Orgánica, Facultad de Química y de Farmacia, Pontificia Universidad Católica de Chile, Av. Vicuña Mackenna 4860, Macul, Santiago 7820436, Chile.; Center for The Development of Nanoscience & Nanotechnology (CEDENNA), Universidad de Santiago de Chile, Santiago 8350709, Chile., Carmona T; Laboratory of Nanomedicine and Targeted Delivery, School of Medicine, Universidad de Talca, Talca 3460000, Chile.; Center for The Development of Nanoscience & Nanotechnology (CEDENNA), Universidad de Santiago de Chile, Santiago 8350709, Chile.; Departamento de Química Analítica, Química Física e Ingeniería Química and Instituto de Investigación Química 'Andrés M. Del Rio' (IQAR), Universidad de Alcalá, 28805 Alcalá de Henares, Madrid, Spain.; Materials Chemistry Department, Faculty of Chemistry and Biology, University of Santiago of Chile (USACH), Santiago 9170022, Chile., Zacconi FC; Departamento de Química Orgánica, Facultad de Química y de Farmacia, Pontificia Universidad Católica de Chile, Av. Vicuña Mackenna 4860, Macul, Santiago 7820436, Chile.; Institute for Biological and Medical Engineering, Schools of Engineering, Medicine and Biological Sciences, Pontificia Universidad Católica de Chile, Av. Vicuña Mackenna 4860, Macul, Santiago 7820436, Chile.; Center for Nanomedicine, Diagnostic & Drug Development (cND3), Universidad de Talca, Talca 3460000, Chile., Venegas-Yazigi D; Center for The Development of Nanoscience & Nanotechnology (CEDENNA), Universidad de Santiago de Chile, Santiago 8350709, Chile.; Materials Chemistry Department, Faculty of Chemistry and Biology, University of Santiago of Chile (USACH), Santiago 9170022, Chile., Cabello-Verrugio C; Center for The Development of Nanoscience & Nanotechnology (CEDENNA), Universidad de Santiago de Chile, Santiago 8350709, Chile.; Laboratory of Muscle Pathology, Fragility and Aging, Faculty of Life Sciences, Universidad Andres Bello, Santiago 8370035, Chile.; Millennium Institute on Immunology and Immunotherapy, Faculty of Life Sciences, Universidad Andres Bello, Santiago 8370035, Chile., Il Choi W; Center for Bio-Healthcare Materials, Bio-Convergence Materials R&D Division, Korea Institute of Ceramic Engineering and Technology, 202, Osongsaengmyeong 1-ro, Osong-eup, Heungdeok-gu, Cheongju 28160, Chungbuk, Republic of Korea., Vilos C; Laboratory of Nanomedicine and Targeted Delivery, School of Medicine, Universidad de Talca, Talca 3460000, Chile.; Center for The Development of Nanoscience & Nanotechnology (CEDENNA), Universidad de Santiago de Chile, Santiago 8350709, Chile.; Center for Nanomedicine, Diagnostic & Drug Development (cND3), Universidad de Talca, Talca 3460000, Chile.

Publikováno v: Pharmaceutics [Pharmaceutics] 2022 Dec 20; Vol. 15 (1). Date of Electronic Publication: 2022 Dec 20.

Combined Administration of Andrographolide and Angiotensin- (1-7) Synergically Increases the Muscle Function and Strength in Aged Mice.

Autor: Abrigo J; Laboratory of Muscle Pathology, Fragility and Aging, Department of Biological Sciences, Faculty of Life Sciences, Universidad Andres Bello. Santiago, Chile.; Millennium Institute on Immunology and Immunotherapy. Santiago, Chile.; Center for the Development of Nanoscience and Nanotechnology (CEDENNA), Universidad de Santiago de Chile. Santiago, Chile., Simon F; Millennium Institute on Immunology and Immunotherapy. Santiago, Chile.; Laboratory of Integrative Physiopathology, Department of Biological Sciences, Faculty of Life Sciences, Universidad Andres Bello. Santiago, Chile.; Millennium Nucleus of Ion Channel-Associated Diseases (MiNICAD), Universidad de Chile. Santiago, Chile., Cabrera D; Departamento de Gastroenterología, Facultad de Medicina, Pontificia Universidad Católica de Chile. Santiago, Chile.; Facultad de Ciencias Médicas, Universidad Bernardo O Higgins. Santiago, Chile., Vilos C; Center for the Development of Nanoscience and Nanotechnology (CEDENNA), Universidad de Santiago de Chile. Santiago, Chile.; Laboratory of Nanomedicine and Targeted Delivery, Center for Medical Research, School of Medicine, Universidad de Talca. Talca, Chile., Cabello-Verrugio C; Laboratory of Muscle Pathology, Fragility and Aging, Department of Biological Sciences, Faculty of Life Sciences, Universidad Andres Bello. Santiago, Chile.; Millennium Institute on Immunology and Immunotherapy. Santiago, Chile.; Center for the Development of Nanoscience and Nanotechnology (CEDENNA), Universidad de Santiago de Chile. Santiago, Chile.

Publikováno v: Current molecular medicine [Curr Mol Med] 2022; Vol. 22 (10), pp. 908-918.

Scaffold biomaterials and nano-based therapeutic strategies for skeletal muscle regeneration.

Autor: Tacchi F; Department of Biological Sciences, Laboratory of Muscle Pathology, Fragility & Aging, Faculty of Life Sciences, Universidad Andres Bello, Santiago, 8370146, Chile.; Millennium Institute on Immunology & Immunotherapy, Santiago, 8370146, Chile.; Center for The Development of Nanoscience & Nanotechnology (CEDENNA), Universidad de Santiago de Chile, Santiago, 8350709, Chile., Orozco-Aguilar J; Department of Biological Sciences, Laboratory of Muscle Pathology, Fragility & Aging, Faculty of Life Sciences, Universidad Andres Bello, Santiago, 8370146, Chile.; Millennium Institute on Immunology & Immunotherapy, Santiago, 8370146, Chile.; Center for The Development of Nanoscience & Nanotechnology (CEDENNA), Universidad de Santiago de Chile, Santiago, 8350709, Chile., Gutiérrez D; Department of Biological Sciences, Laboratory of Muscle Pathology, Fragility & Aging, Faculty of Life Sciences, Universidad Andres Bello, Santiago, 8370146, Chile.; Millennium Institute on Immunology & Immunotherapy, Santiago, 8370146, Chile.; Center for The Development of Nanoscience & Nanotechnology (CEDENNA), Universidad de Santiago de Chile, Santiago, 8350709, Chile., Simon F; Millennium Institute on Immunology & Immunotherapy, Santiago, 8370146, Chile.; Millennium Nucleus of Ion Channel-Associated Diseases (MiNICAD),Universidad de Chile, Santiago, 8370146, Chile.; Department of Biological Sciences, Laboratory of Integrative Physiopathology, Faculty of Life Sciences, Universidad Andres Bello, Santiago, 8370146, Chile., Salazar J; Center for The Development of Nanoscience & Nanotechnology (CEDENNA), Universidad de Santiago de Chile, Santiago, 8350709, Chile.; Laboratory of Nanomedicine & Targeted Delivery, Center for Medical Research, School of Medicine, Universidad de Talca, Talca, 3460000, Chile., Vilos C; Center for The Development of Nanoscience & Nanotechnology (CEDENNA), Universidad de Santiago de Chile, Santiago, 8350709, Chile.; Laboratory of Nanomedicine & Targeted Delivery, Center for Medical Research, School of Medicine, Universidad de Talca, Talca, 3460000, Chile., Cabello-Verrugio C; Department of Biological Sciences, Laboratory of Muscle Pathology, Fragility & Aging, Faculty of Life Sciences, Universidad Andres Bello, Santiago, 8370146, Chile.; Millennium Institute on Immunology & Immunotherapy, Santiago, 8370146, Chile.; Center for The Development of Nanoscience & Nanotechnology (CEDENNA), Universidad de Santiago de Chile, Santiago, 8350709, Chile.

Publikováno v: Nanomedicine (London, England) [Nanomedicine (Lond)] 2021 Dec; Vol. 16 (28), pp. 2521-2538. Date of Electronic Publication: 2021 Nov 08.